Search hospitals > Maryland > Baltimore
Johns Hopkins University/Sidney Kimmel Cancer Center
Claim this profileBaltimore, Maryland 21205
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Pancreatic Cancer
Conducts research for Solid Tumors
Conducts research for Lymphoma
1104 reported clinical trials
85 medical researchers
Summary
Johns Hopkins University/Sidney Kimmel Cancer Center is a medical facility located in Baltimore, Maryland. This center is recognized for care of Cancer, Breast Cancer, Pancreatic Cancer, Solid Tumors, Lymphoma and other specialties. Johns Hopkins University/Sidney Kimmel Cancer Center is involved with conducting 1,104 clinical trials across 815 conditions. There are 85 research doctors associated with this hospital, such as Kenneth J. Cohen, Nilofer S. Azad, Michael J. Pishvaian, and Channing Paller, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
HER2 negative
HER2 positive
Top PIs
Kenneth J. CohenJohns Hopkins University/Sidney Kimmel Cancer Center8 years of reported clinical research
Expert in Brain Tumor
Expert in Brain Cancer
52 reported clinical trials
98 drugs studied
Nilofer S. AzadJohns Hopkins University/Sidney Kimmel Cancer Center7 years of reported clinical research
Studies Bile Duct Cancer
Studies Cancer
15 reported clinical trials
29 drugs studied
Michael J. PishvaianSibley Memorial Hospital4 years of reported clinical research
Studies Pancreatic Cancer
Studies Solid Tumors
17 reported clinical trials
38 drugs studied
Channing Paller, MDSibley Memorial Hospital2 years of reported clinical research
Expert in Prostate Cancer
Studies Lung Cancer
12 reported clinical trials
25 drugs studied
Clinical Trials running at Johns Hopkins University/Sidney Kimmel Cancer Center
Lung Cancer
Breast Cancer
Bladder Cancer
Prostate Cancer
Ovarian Cancer
Pancreatic Cancer
Uterine Cancer
Wilms Tumor
Testicular cancer
Skin Cancer
Thoracotomy vs Thoracoscopy
for Metastatic Osteosarcoma
This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through a single larger incision (like a large cut) that goes between the ribs, opens up the chest, and removes the cancer. Thoracoscopy is a type of chest surgery where the doctor makes several small incisions and uses a small camera to help with removing the cancer. This trial is being done evaluate the two different surgery methods for patients with osteosarcoma that has spread to the lung to find out which is better.
Recruiting2 awards Phase 37 criteria
Proton Craniospinal Radiation
for Cancer in the Brain and Spinal Cord
This phase III trial compares proton craniospinal irradiation (pCSI) to involved-field radiation therapy (IFRT) for the treatment of breast or non-small cell lung cancer that has spread from where it first started to the cerebrospinal fluid filled space that surrounds the brain and spinal cord (leptomeningeal metastasis). Patients with leptomeningeal metastasis (LM) may develop multiple areas of nervous system (neurologic) impairment that can be life-threatening. Radiation therapy (RT) effectively relieves local symptoms due to LM. RT uses high energy radiography (x-rays), particles, or radioactive seeds to kill cancer cells and shrink tumors. IFRT is commonly used to treat symptoms of LM. IFRT is radiation treatment that uses x-rays to treat specific areas of LM and to relieve and/or prevent symptoms. pCSI uses protons that can be directed with more accuracy than x-rays which allows treatment of the entire central nervous system space containing the cerebrospinal fluid (CSF), brain, and spinal cord. The pCSI treatment could delay the worsening of LM. Giving pCSI may be better than IFRT in treating LM in patients with breast or non-small cell lung cancer.
Recruiting2 awards Phase 33 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Johns Hopkins University/Sidney Kimmel Cancer Center?
Johns Hopkins University/Sidney Kimmel Cancer Center is a medical facility located in Baltimore, Maryland. This center is recognized for care of Cancer, Breast Cancer, Pancreatic Cancer, Solid Tumors, Lymphoma and other specialties. Johns Hopkins University/Sidney Kimmel Cancer Center is involved with conducting 1,104 clinical trials across 815 conditions. There are 85 research doctors associated with this hospital, such as Kenneth J. Cohen, Nilofer S. Azad, Michael J. Pishvaian, and Channing Paller, MD.
Where is Johns Hopkins University/Sidney Kimmel Cancer Center located?
The Johns Hopkins Kimmel Cancer Center is situated in the Weinberg Building on Broadway Street, Baltimore, MD. For access, proceed on Broadway, then turn right onto Jefferson Street after Orleans Street.
Who should I call to ask about financial aid or insurance network?
**Johns Hopkins University/Sidney Kimmel Cancer Center Contact Information:**
**Financial Assistance:**
- Medical Oncology: 410-502-1304 or 410-955-8995
- Radiation Oncology: 410-614-1358 or 410-502-1643
**Student Financial Support:**
- Undergraduate Students: 410-516-8028
- Graduate Students: Visit the SEAM contact page for a dedicated adviser.
What insurance does Johns Hopkins University/Sidney Kimmel Cancer Center accept?
The Johns Hopkins University/Sidney Kimmel Cancer Center accepts a variety of insurance plans, such as Aetna, CareFirst BlueCross BlueShield, Cigna Healthcare, and UnitedHealthcare, among others. Coverage may vary based on insurance product type, employer benefit design, and physician location or specialty, so it's crucial to contact the insurer directly to confirm. Most Johns Hopkins Medicine hospitals and physicians participate with Medicare Advantage Plans, but patients should verify if an authorization and/or referral is necessary for services at specific facilities.
What awards or recognition has Johns Hopkins University/Sidney Kimmel Cancer Center received?
Johns Hopkins University's Sidney Kimmel Comprehensive Cancer Center, located in Baltimore, Maryland, was renamed in honor of philanthropist Sidney Kimmel following his $150 million donation for cancer research and patient care. The center is celebrated for its pioneering surgical treatments and extensive research in areas such as the genetic basis of colon cancer, cancer pain treatment, gene therapy, and innovative therapies for breast cancer. It has also gained acclaim for its researchers being named to the National Academy of Inventors, underscoring their significant contributions to science and society.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.